Alvotech Sees Out 2025 With Simponi Biosimilar Debut In Europe

Launch Of Golimumab Rival Gobivaz Via Advanz Includes UK Roll-Out

 
• By Dave Wallace
  
Alvotech and Advanz have launched Gobivaz in Europe (Shutterstock)

More from Biosimilars

More from Products